Coloplast AS (OCSE:COLO B) EV-to-EBITDA : 24.45 (As of Dec. 15, 2024)

Coloplast AS EV-to-EBITDA Chart

Coloplast AS Annual Data
	Trend	Sep15	Sep16	Sep17	Sep18	Sep19	Sep20	Sep21	Sep22	Sep23	Sep24
EV-to-EBITDA		Get a 7-Day Free Trial					33.81	30.68	25.28	24.13	25.83

Coloplast AS Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
EV-to-EBITDA	Get a 7-Day Free Trial															24.13	24.28	28.58	25.38	25.83

Competitive Comparison of Coloplast AS's EV-to-EBITDA

For the Medical Instruments & Supplies subindustry, Coloplast AS's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Coloplast AS's EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Coloplast AS's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Coloplast AS's EV-to-EBITDA falls into.

Coloplast AS EV-to-EBITDA Calculation

Coloplast AS's EV-to-EBITDA for today is calculated as:

Coloplast AS's current Enterprise Value is kr207,608 Mil.
Coloplast AS's EBITDA for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr8,490 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Coloplast AS  (OCSE:COLO B) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Coloplast AS's PE Ratio (TTM) for today is calculated as:

Coloplast AS's share price for today is kr824.40.
Coloplast AS's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr22.460.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?

Coloplast AS EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Coloplast AS's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Coloplast AS Business Description